CL Educate Ltd (NSE:CLEDUCATE)
₹ 59.87 -0.13 (-0.22%) Market Cap: 3.25 Bil Enterprise Value: 2.98 Bil PE Ratio: 0 PB Ratio: 1.28 GF Score: 63/100

Q1 2027 CL Educate Ltd Earnings Call Transcript

Aug 5, 2026 / 10:00 AM GMT
Release Date Price: ₹58.78 (+3.69%)

Key Points

Positve
  • EBITDA margin expanded by 218 basis points to 16.6% despite revenue challenges, driven by cost optimization.
  • Cost rationalization efforts led to an 8.7 crore reduction in fixed overhead costs compared to Q1 last year.
  • MarTech business showed strong profitability with a 35% increase in EBIT on a 7% revenue growth.
  • EasyApply platform adoption is expanding, with most top management institutes now onboard, and early signs of strong growth in the new admission cycle.
  • NCLT approval for the capital reduction scheme for RPS shares is a positive step towards balance sheet optimization and debt reduction.
  • DexIT's advanced AI-enabled proctoring technology positions the company well to benefit from increased scrutiny and potential regulatory reforms in the assessment sector.
  • Versa, the AI-driven MarTech tool, has successfully completed pilots with major clients like Salesforce, Dell, and Infosys, and is scaling up for broader adoption.
  • The company is on track to achieve its goal of becoming net debt zero within three years, with current debt repayments on schedule.
  • New contract wins in the tax business (9 contracts worth 34 crore) provide revenue visibility for the current and next fiscal year.
  • The company is leveraging AI to accelerate innovation and reduce costs, with 74% of coding now AI-enabled.
Negative
  • Revenue declined by 17.5 crore in Q1, with a 15% drop in the test prep business due to market churn and structural headwinds.
  • The company remains loss-making at the after-tax level due to interest and depreciation charges, despite improved EBITDA.
  • Digital assessment revenue fell 17% due to exam rollovers and delayed revenue recognition of 4.7 crore, impacting Q1 results.
  • The test prep segment faces significant challenges from AI-driven free online resources and structural market readjustments, particularly in the MBA vertical.
  • Finance costs, though reduced, remain high at 10.6 crore, and depreciation increased by 28% due to new fixed assets.
  • The rationalization of exams could lead to the disappearance of some existing exams, creating uncertainty for the assessment business.
  • The company's reliance on government tenders (60-65% of DexIT business) exposes it to pricing pressure and competition from low-cost bidders.
  • Q1 is seasonally the weakest quarter for MarTech and digital assessments, leading to lower revenue and profitability.
  • The company's growth plans require cash, limiting the pace of debt reduction despite the goal of net zero debt.
  • The test prep business saw a decline in volumes that was not fully compensated by price increases, impacting overall revenue.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CARU.NS - CL Educate Ltd
Q1 2027 CL Educate Ltd Earnings Call
Aug 05, 2026 / 10:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for your patience and good afternoon once again, ladies and gentlemen, and welcome to CL Educate Limited's Q1 FY27 analyst call.

My name is Arjun Watwa. I'm the group CFO of CL Educate and I'll be your host today.

Welcome once again to our metaverse platform called Vosmos, now in its 4th year for our analyst calls.

This call, as always, will be recorded, transcribed and made available in the investor zone on our website within the next 24 to 48 hours.

Should you have any questions during the session, please feel free to type them in the chat box in the bottom right hand corner of your screen.

We will address them at the end of the session.

Joining me on this conference call
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot